How to Trip Rapid Review

Step 1: Select articles relevant to your search (remember the system is only optimised for single intervention studies)

Step 2: press

Step 3: review the result, and maybe amend the or if you know better! If we're unsure of the overall sentiment of the trial we will display the conclusion under the article title. We then require you to tell us what the correct sentiment is.

548 results for

Shave Biopsy

by
...
Latest & greatest
Alerts

Export results

Use check boxes to select individual results below

SmartSearch available

Trip's SmartSearch engine has discovered connected searches & results. Click to show

1. The increasing use of shave biopsy for diagnosing invasive melanoma in Australia. (PubMed)

The increasing use of shave biopsy for diagnosing invasive melanoma in Australia. To assess changes in the choice of skin biopsy technique for assessing invasive melanoma in Victoria, and to examine the impact of partial biopsy technique on the accuracy of tumour microstaging.Retrospective cross-sectional review of Victorian Cancer Registry data on invasive melanoma histologically diagnosed in Victoria during 2005, 2010, and 2015.400 patients randomly selected from each of the three years (...) ); the proportion of shave biopsies increased from 9% in 2005 to 20% in 2015 (P < 0.001), with increasing rates among dermatologists and general practitioners. Ninety-four of 175 shave biopsies (54%) transected the tumour base; wide local excision subsequently identified residual melanoma in 65 of these cases (69%). Twenty-one tumours diagnosed by shave biopsy (12%) were T-upstaged. With base-transected shave biopsies, tumour thickness was underestimated by a mean 2.36 mm for thick, 0.48 mm for intermediate

2019 Medical Journal of Australia

2. Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients. (PubMed)

Residual Squamous Cell Carcinoma After Shave Biopsy in Solid Organ Transplant Recipients. After histopathological confirmation of a biopsy sample, cutaneous squamous cell carcinoma (cSCC) is often treated surgically; yet, residual tumor within the excision sample is not always found. The prevalence of residual cSCC after shave biopsy in solid organ transplant recipients (SOTRs) is unknown.Determine the prevalence of residual cSCC after shave biopsy in SOTRs.A retrospective case-controlled (...) review was performed from a single center. Data were collected for 117 SOTRs and 117 age-matched nonimmunosuppressed controls diagnosed with shave biopsy-proven cSCC who underwent subsequent wide local excision from January 2004 to December 2016. Multivariable conditional logistic regression was used to determine variables associated with residual tumor in the combined population. Univariate logistic regression was used to investigate if transplant-related variables were associated with residual

2018 Dermatologic Surgery

3. Initial Misidentification of Thumb Poroma by Shave Biopsy. (PubMed)

Initial Misidentification of Thumb Poroma by Shave Biopsy. Poromas are benign adnexal neoplasms originating from the intraepidermal portion of sweat gland ducts. With the possibility of malignant transformation, accurate clinical diagnosis and treatment are crucial. Numerous reports of hand poroma lesions have been reported. We present an unusual case of a distal thumb poroma originally identified as a squamous cell lesion in a shave biopsy and eventually accurately identified after excisional (...) biopsy. This report highlights the limitations of shave biopsy associated with soft tissue hand lesions and the need to consider poroma when evaluating a soft tissue lesion of the hand.Copyright © 2019 American Society for Surgery of the Hand. Published by Elsevier Inc. All rights reserved.

2018 Journal of Hand Surgery - American

4. The Ram Relaxation Technique: A Painless Biopsy Method. A Shave Biopsy Approach Without Injectable Anesthesia or Needles. (PubMed)

The Ram Relaxation Technique: A Painless Biopsy Method. A Shave Biopsy Approach Without Injectable Anesthesia or Needles. Shave skin biopsies are essential procedures wherein physicians diagnose dermatologic lesions. The protocol for skin biopsies entails a lidocaine/epinephrine injection. This study suggests an alternative, novel method of performing a shave biopsy that avoids pain, needles, and injectable anesthesia, termed the Ram Relaxation Technique (RRT).To present a new technique (...) that physicians may chose to form when faced with dermatological biopsies that are painless and needle free.Randomly selected, patients were presented to the authors' offices with abnormal skin lesions that required a shave biopsy. The patients were offered the choice of having an anesthetic injection (1% lidocaine, 1:100,000 epinephrine) or the alternative method (RRT) before the biopsy. Twenty patients (n = 20, 10 men, 10 women) chose the alternative method (RRT) and were the focus of this study

2016 Dermatologic Surgery

5. Shave Biopsy

Shave Biopsy Shave Biopsy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Shave Biopsy Shave Biopsy Aka: Shave Biopsy , Tangential (...) Biopsy , Transverse Sectioning II. Indications: Elevated (exophytic) neoplasms Non-pigmented Keratocanthoma Cutaneous horn Possible small localized low-risk cancer Squamous cell cancer III. Contraindications Do not Shave Biopsy possible s! Do not Shave Biopsy pigmented lesions (may be ) Avoid Shave Biopsy of subcutaneous lesions IV. Technique Prep lesion with povidone- (Betadine) or chlorhexidine (Hibiclens) with intradermal Adequate anesthesia requires 1 cm wheal around lesion Anesthesia also raises

2018 FP Notebook

6. Punch Biopsy Versus Shave Biopsy: A Comparison of Margin Status of Clinically Atypical Pigmented Lesions. (PubMed)

Punch Biopsy Versus Shave Biopsy: A Comparison of Margin Status of Clinically Atypical Pigmented Lesions. 25864555 2016 07 11 2015 09 25 1365-2133 173 3 2015 Sep The British journal of dermatology Br. J. Dermatol. Punch biopsy vs. shave biopsy: a comparison of margin status of clinically atypical pigmented lesions. 849-51 10.1111/bjd.13830 Cheng R R Duke University School of Medicine, Durham, NC, U.S.A. Bialas R W RW Department of Dermatology, Duke University Medical Center, Durham, NC, U.S.A (...) . Chiu S T ST Department of Biostatistics and Bioinformatics, Duke University School of Medicine, Durham, NC, U.S.A. Lawrence T J TJ Department of Pathology, Duke University Medical Center, Durham, NC, U.S.A. Lesesky E B EB Department of Dermatology, Duke University Medical Center, Durham, NC, U.S.A. eng Comparative Study Letter Research Support, Non-U.S. Gov't 2015 08 19 England Br J Dermatol 0004041 0007-0963 IM Biopsy methods Diagnosis, Differential Dysplastic Nevus Syndrome pathology Humans

2015 British Journal of Dermatology

7. To Scoop or Not to Scoop: The Diagnostic and Therapeutic Utility of the Scoop-Shave Biopsy for Pigmented Lesions. (PubMed)

To Scoop or Not to Scoop: The Diagnostic and Therapeutic Utility of the Scoop-Shave Biopsy for Pigmented Lesions. Concern over transection of melanomas has inhibited many practitioners from using the scoop-shave for removal of pigmented lesions.To assess the safety and efficacy of the scoop-shave for pigmented lesions.The practitioner's clinical diagnosis, intent (sample or completely remove), and removal technique (excision, punch, shave biopsy, or scoop-shave) were recorded. Pathology results (...) intent was "complete removal," the lesion was completely removed 73.1% of the time by scoop-shave, 91% by standard excision, 18.1% by shave biopsy, and 78.6% by punch excision (p < .0001).The scoop-shave is a safe and effective technique for diagnosis and treatment of melanocytic lesions.

2014 Dermatologic Surgery

8. Recurrence of Dysplastic Nevi Is Strongly Associated with Extension of the Lesions to the Lateral Margins and into the Deep Margins through the Hair Follicles in the Original Shave Removal Specimens (PubMed)

following incomplete removal. The present study determines the rate and etiology of this event. A cross-sectional analysis of 110 excision specimens showing histological recurrence was performed, and these specimens were compared to the slides of the original shave specimens showing mildly atypical DN. In the second portion of the study, a retrospective review of 167 cases with biopsy-proven mildly atypical DN which were followed up for at least two years was conducted to determine the rate (...) Recurrence of Dysplastic Nevi Is Strongly Associated with Extension of the Lesions to the Lateral Margins and into the Deep Margins through the Hair Follicles in the Original Shave Removal Specimens Melanocytic nevi, including dysplastic or atypical nevi (DN), can recur or persist following shave removal procedures, and recurrence may resemble melanoma, both clinically and histologically (pseudomelanoma). Recurrence may originate from proliferation of the remaining neoplastic melanocytes

Full Text available with Trip Pro

2016 Dermatology research and practice

9. Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients

Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients Cavity Shaving in Breast Conserving Surgery for Breast Cancer Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Cavity Shaving (...) provided by (Responsible Party): Fengxi Su, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Study Details Study Description Go to Brief Summary: This randomized controlled trial is to evaluate the impact of additional cavity shaving (CS) on pathological cavity margin (CM) status in breast cancer patients. Patients receiving standard breast-conserving surgery (BCS) will be randomized to intra-operative CM assessment versus intra-operative CS followed by CM assessment. The primary objective

2016 Clinical Trials

10. Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients

Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients Shave Margins vs. Standard Partial Mastectomy in Breast Cancer Patients - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Shave Margins (...) Party): Yale University Study Details Study Description Go to Brief Summary: Breast cancer is the most common malignancy affecting women in the US. Surgical management is the mainstay of therapy, and in general consists of resection of the primary tumor with either a partial mastectomy (aka "lumpectomy") or a total mastectomy. The investigators hypothesize that routine shave margins during partial mastectomy will significantly reduce positive margin rate. A positive margin means that cancerous cells

2016 Clinical Trials

11. Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies. (PubMed)

Comparative study of the efficacy and tolerability of a unique topical scar product vs white petrolatum following shave biopsies. An excess of 70 million cutaneous surgical procedures are conducted annually in the United States that may result in scarring. Skin scars are a normal outcome of the tissue repair process. However, individuals with abnormal scarring may have aesthetic, psychological, and social consequences. As a result, there is a high patient demand for products that will reduce (...) the scarring. The principles underlying scar formation are now better understood. Products are being developed to address those critical components of the wound-healing process, namely inflammation, hydration, and collagen maturation. A multicomponent scar product was previously shown effective in preventing exaggerated scarring in patients undergoing various surgical procedures. The present outpatient study was conducted in patients undergoing shave biopsies. Following reepithelialization

2013 Journal of drugs in dermatology : JDD

12. Incidence of Residual Nonmelanoma Skin Cancer in Excisions After Shave Biopsy. (PubMed)

Incidence of Residual Nonmelanoma Skin Cancer in Excisions After Shave Biopsy. Nonmelanoma skin cancer is an increasingly common disease that is typically treated surgically. After histopathologic confirmation by biopsy, the carcinoma is typically removed by excision, but not all excisional specimens contain residual carcinoma.To define the rate of residual basal and squamous cell carcinomas within excisional specimens after shave biopsy in a general dermatology office.We retrospectively (...) positive residuals. Histologic type was significantly associated (p = .002) with residual carcinoma in excisional specimens, with basal cells 2.13 times as likely to have residual carcinoma present.The rate of residual nonmelanoma carcinoma in excision specimens after shave biopsy was found to be different from previously reported in the literature. These data may have therapeutic ramifications if further substantiated.© 2012 by the American Society for Dermatologic Surgery, Inc. Published by Wiley

2012 Dermatologic Surgery

13. Shave Biopsy

Shave Biopsy Shave Biopsy Toggle navigation Brain Head & Neck Chest Endocrine Abdomen Musculoskeletal Skin Infectious Disease Hematology & Oncology Cohorts Diagnostics Emergency Findings Procedures Prevention & Management Pharmacy Resuscitation Trauma Emergency Procedures Ultrasound Cardiovascular Emergencies Lung Emergencies Infectious Disease Pediatrics Neurologic Emergencies Skin Exposure Miscellaneous Abuse Cancer Administration 4 Shave Biopsy Shave Biopsy Aka: Shave Biopsy , Tangential (...) Biopsy , Transverse Sectioning II. Indications: Elevated (exophytic) neoplasms Non-pigmented Keratocanthoma Cutaneous horn Possible small localized low-risk cancer Squamous cell cancer III. Contraindications Do not Shave Biopsy possible s! Do not Shave Biopsy pigmented lesions (may be ) Avoid Shave Biopsy of subcutaneous lesions IV. Technique Prep lesion with povidone- (Betadine) or chlorhexidine (Hibiclens) with intradermal Adequate anesthesia requires 1 cm wheal around lesion Anesthesia also raises

2015 FP Notebook

14. Accuracy of partial biopsies in the management of cutaneous melanoma. (PubMed)

Accuracy of partial biopsies in the management of cutaneous melanoma. The recommended method for histopathological diagnosis of cutaneous melanoma is excisional biopsy, although partial biopsies (shave and punch) are often used. Following a partial biopsy, treatment guidelines recommend a narrow excisional biopsy to plan definitive management. There is limited evidence on the benefits of direct wide local excision (WLE) following diagnostic partial biopsies.Retrospective cohort study (...) of cutaneous melanoma cases, from two tertiary referral centres from January 2013 to December 2015. Demographic and histopathological data, including tumour thickness (T-stage) from initial biopsy and subsequent excisions, were collected. Logistic regression was used to examine histopathological T-staging between biopsy and subsequent excisions (upstaging).2304 melanomas (2157 patients) were identified; 455 shave, 308 punch, 14 incisional and 1527 excisional biopsies. Out of 1527, 5 (<1%) excisional

2019 Australasian Journal of Dermatology

15. Wide local excision prior to sentinel lymph node biopsy for primary melanoma of the head and neck. (PubMed)

the years 2000 and 2016, 391 cases were reviewed with a median follow-up time of 30 months in a large tertiary care center. Biopsy practices included shave, punch, wide local excision, and narrow margin excisional/Mohs, and associations with time to local or regional relapse and death from melanoma were evaluated. Main outcomes included identification of sentinel lymph nodes, overall survival, and melanoma-specific survival.Of the 391 patients, biopsy patterns were as follows: 77 (19%) unknown biopsy (...) , 30 (8%) prior wide local excision (WLE), 105 (27%) narrow margin excisional biopsy, 69 (18%) punch biopsy, and 110 (28%) shave biopsy. SLNB was successfully identified in all 30 patients whom had a prior WLE. There were 50 regional recurrences in the neck and 27 local recurrences with the median (IQR) at 1.2 years and 1.0 years, respectively. Multivariable associations of type of prior biopsy, depth of invasion, and nodal status with time to regional recurrence, local recurrence, overall survival

2019 International Journal of Dermatology

16. Negative Predictive Value of Biopsy Margins in Keratinocyte Carcinoma: A Literature Review. (PubMed)

Negative Predictive Value of Biopsy Margins in Keratinocyte Carcinoma: A Literature Review. Pathologists sometimes include commentary on margin involvement in shave biopsy reports of keratinocyte carcinoma (KC). This practice can lead to confusion regarding the need for further treatment. There is limited literature evaluating the reliability of reported histologic margin status in shave biopsies of KC.To evaluate the negative predictive value (NPV) of reported clear shave biopsy margins (...) initially noted to have negative margins on biopsy were found to have residual tumor on subsequent analysis: 5 SCC and 50 BCC, translating to 12.8% of all SCC (5/39) and 27.5% for BCC (50/182). Negative predictive values were found to be 75.1% for all KCs, 87.2% for SCC, and 72.5% for BCC.Negative histologic margin status on shave biopsy specimens of KC has a poor NPV and is an inadequate predictor for complete tumor removal.

2019 Dermatologic Surgery

17. Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. (PubMed)

Shave biopsy is a safe and accurate method for the initial evaluation of melanoma. Shave biopsy of cutaneous lesions is simple, efficient, and commonly used clinically. However, this technique has been criticized for its potential to hamper accurate diagnosis and microstaging of melanoma, thereby complicating treatment decision-making.We retrospectively analyzed a consecutive series of patients referred to the University of Florida Shands Cancer Center or to the Moffitt Cancer Center (...) for treatment of primary cutaneous melanoma, initially diagnosed on shave biopsy to have Breslow depth < 2 mm, to determine the accuracy of shave biopsy in T-staging and the potential impact on definitive surgical treatment and outcomes.Six hundred patients undergoing shave biopsy were diagnosed with melanoma from extremity (42%), trunk (37%), and head or neck (21%). Mean (± SEM) Breslow thickness was 0.73 ± 0.02 mm; 6.2% of lesions were ulcerated. At the time of wide excision, residual melanoma was found

Full Text available with Trip Pro

2011 Journal of the American College of Surgeons

18. Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery. (PubMed)

Histological evaluation of residual basal cell carcinoma after shave biopsy prior to Mohs micrographic surgery. Patients who are referred for Mohs surgery after pre-operative biopsy has been performed show in some cases no clinical or pathological evidence of tumour persistence. We have previously shown that 25% of these patients show no residual skin cancer either basal cell carcinoma or squamous cell carcinoma. The reasons for 'disappearance' of the tumour may be true non-persistence or false (...) non-persistence because of wrong-site Mohs surgery.To determine the incidence of residual basal cell carcinoma after shave biopsy of primary nodular basal cell carcinoma prior to Mohs micrographic surgery.A prospective unblinded study was performed on patients undergoing Mohs surgery for primary nodular basal cell carcinoma. The tumour was removed as a shaved excision using a No. 15 blade at the clinical borders like a shave biopsy (Mohs shave). The bases of the tumors were excised

2011 Journal of the European Academy of Dermatology and Venereology

19. Skin biopsy: punch method

a skin biopsy such as a punch biopsy, shave biopsy or surgical excision of part of a lesion ( ). A punch skin biopsy is considered the best technique to obtain diagnostic full thickness skin specimens ( ). A circular blade is rotated into the skin through to the subcutaneous fat, obtaining a cylindrical specimen which is then histologically examined ( ). Punch skin biopsies are useful in investigating neoplasms, pigmented lesions, inflammatory lesions and chronic skin disorders ( ). The procedure may (...) Skin biopsy: punch method Skin biopsy: punch method | Great Ormond Street Hospital Google Tag Manager Navigation Search Search You are here Skin biopsy: punch method Skin biopsy: punch method ). NOTE: We review our guidelines regularly and this guideline is now past its review date. The content of the guideline below may not reflect the most recent evidence based practice. Please use with caution. Children and young people can present with a wide range of skin anomalies. Some of these can prove

2014 Great Ormond Street Hospital

20. Shave Margins in Breast Conservation Therapy

Shave Margins in Breast Conservation Therapy Shave Margins in Breast Conservation Therapy - Full Text View - ClinicalTrials.gov Hide glossary Glossary Study record managers: refer to the if submitting registration or results information. Search for terms x × Study Record Detail Saved Studies Save this study Warning You have reached the maximum number of saved studies (100). Please remove one or more studies before adding more. Shave Margins in Breast Conservation Therapy (SMART) The safety (...) Description Go to Brief Summary: The investigators propose a randomized controlled superiority trial of standard breast-conserving surgery (BCS) versus BCS with cavity shave margins (CSM). The main objectives of this trial will be to evaluate prospectively the impact of routine standardized CSM on margin status following primary surgery for early stage breast cancer (Stage 0 - II), on post-operative patient satisfaction and cosmetic outcomes, and on general intraoperative time and operative costs

2015 Clinical Trials

To help you find the content you need quickly, you can filter your results via the categories on the right-hand side >>>>